2024-08-31 22:12:03
Unicef announced on Saturday August 31 that it has been launched “emergency call for clothes” in order to get vaccines against mpox to be able to help the worst affected countries. “Depending on demand, the production capacity of manufacturers and financing, contracts covering a maximum of twelve million in 2025 can be put in place”said Unicef communiquéreleased with the World Health Organization, Gavi Vaccine Alliance and Africa CDC (African Centers for Disease Control and Prevention). This “We designed an emergency cold to ensure immediate access to available mpox vaccines and to increase production”specify the release button.
As part of this call for grants, Unicef wants to put supply contracts in place that allow it to receive and distribute vaccines. “Without delay, once countries and partners have secured funding, confirmed needs and their level of preparedness, and the regulatory requirements for receiving the vaccine are in place”.
The return of mpox in Africa, which affects the Democratic Republic of Congo (DRC) and other countries on the continent (especially Burundi, Kenya, Rwanda and Uganda), and the appearance of a new variant (1b) has pushed the WHO to withdraw it. the highest level of global health alert on August 14.
More than 200 deaths in the Democratic Republic of Congo
More than 18,000 suspected cases of mpox, including 629 deaths, have been reported this year in the DRC, “This is the beginning of the crisis”such as press Release, which you specify “four out of five of the dead are children”. There are two great families, called “clades”of the virus. Clade 1 is located primarily in central Africa, in the Congo basin. Clade 2 is mainly distributed in West Africa. Two subgroups of mpox circulate in the DRC: clade 1a, in the west of the country and clade 1b, in the east.
WHO recommends the use of MVA-BN vaccines, made by the Danish pharmaceutical company Bavarian Nordic Laboratory, or LC16, from the Japanese company KM Biologics, or the ACAM2000 vaccine, made in the United States, when the first two are not available. . MVA-BN and LC16 are not yet accepted “leader” WHO’s comprehensive review, a long and complex process, the organization launched an emergency review.
“WHO is currently reviewing information submitted by manufacturers on August 23 and we expect to complete its review for the emergency use list by mid-September”refer to the press release.
#Faced #mpox #Unicef #launched #call #bonds #receive #vaccines